RNS Number : 2811V
Georgia Healthcare Group PLC
14 April 2016
The following announcement is made in accordance with DTR 5
|
|
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
|
|
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii
|
GEORGIA HEALTHCARE GROUP PLC
|
|
2 Reason for the notification (please tick the appropriate box or boxes):
|
|
An acquisition or disposal of voting rights
|
X
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
|
|
An event changing the breakdown of voting rights
|
|
|
Other (please specify):
|
|
|
|
3. Full name of person(s) subject to the
notification obligation: iii
|
T. Rowe Price Associates, Inc.
|
|
4. Full name of shareholder(s)
(if different from 3.):iv
|
Bank of New York Mellon (FL)
Bank of New York Mellon Bank, N.A.
JP Morgan Chase
State Street Bank & Trust Co
|
|
5. Date of the transaction and date on
which the threshold is crossed or
reached: v
|
08 April 2016
|
|
6. Date on which issuer notified:
|
14 April 2016
|
|
7. Threshold(s) that is/are crossed or
reached: vi, vii
|
5%
|
|
|
|
|
|
|
|
8. Notified details:
|
|
A: Voting rights attached to shares viii, ix
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights x
|
|
Direct
|
Direct xi
|
Indirect xii
|
Direct
|
Indirect
|
|
GB00BYSS4K11
|
6,347,933
|
6,347,933
|
6,860,375
|
|
6,860,375
|
|
5.20%
|
|
|
|
|
|
B: Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Expiration
date xiii
|
Exercise/
Conversion Period xiv
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of voting
rights
|
|
|
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise price
|
Expiration date xvii
|
Exercise/
Conversion period xviii
|
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|
|
|
|
|
|
Nominal
|
Delta
|
|
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
6,860,375
|
5.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
|
|
T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of Georgia Healthcare Group Plc, including the T. Rowe Price International Discovery Fund, Inc., which owns 4,932,042 shares. Such shares are registered in the following name(s):
Bank of New York Mellon (FL) - 97,928
Bank of New York Mellon Bank, N.A. - 136,797
JP Morgan Chase - 6,483,208
State Street Bank & Trust Co. - 142,442
|
|
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
|
|
11. Number of voting rights proxy holder will cease
to hold:
|
|
|
12. Date on which proxy holder will cease to hold
voting rights:
|
|
|
|
|
13. Additional information:
|
|
|
14. Contact name:
|
Gary Greb, Vice President
T. Rowe Price Associates, Inc.
|
|
15. Contact telephone number:
|
001 410 345 2527
|
|
|
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKLLFSKKEFF